Sunshine Biopharma Inc (SBFM) — Cash Flow-to-Debt Ratio
Sunshine Biopharma Inc (SBFM) has a Cash Flow-to-Debt Ratio of -0.23x as of March 2026, meaning its operating cash flow of $-1.62 Million could theoretically repay 0% of its total liabilities ($7.04 Million) in one year. Check Sunshine Biopharma Inc (SBFM) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sunshine Biopharma Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Sunshine Biopharma Inc across 19 annual periods. Also explore total assets of Sunshine Biopharma Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Sunshine Biopharma Inc (2007–2025)
Year-by-year debt coverage analysis for Sunshine Biopharma Inc. For market capitalisation and broader financial context, see Sunshine Biopharma Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.76x | $-5.33 Million | $7.04 Million | ▲ +57.3% |
| 2024 | -1.78x | $-12.53 Million | $7.06 Million | ▼ -24.2% |
| 2023 | -1.43x | $-8.78 Million | $6.14 Million | ▼ -115.6% |
| 2022 | -0.66x | $-5.25 Million | $7.92 Million | ▲ +27.8% |
| 2021 | -0.92x | $-1.83 Million | $1.99 Million | ▼ -179.5% |
| 2020 | -0.33x | $-657.30K | $2.00 Million | ▲ +44.8% |
| 2019 | -0.59x | $-495.80K | $833.53K | ▼ -39.5% |
| 2018 | -0.43x | $-512.81K | $1.20 Million | ▲ +34.8% |
| 2017 | -0.65x | $-543.52K | $830.85K | ▲ +42.9% |
| 2016 | -1.15x | $-314.18K | $274.10K | ▼ -67.8% |
| 2015 | -0.68x | $-867.64K | $1.27 Million | ▲ +32.7% |
| 2014 | -1.01x | $-538.60K | $531.00K | ▲ +93.0% |
| 2013 | -14.49x | $-564.40K | $38.95K | ▼ -137.3% |
| 2012 | -6.11x | $-393.05K | $64.37K | ▲ +92.9% |
| 2011 | -86.58x | $-297.30K | $3.43K | ▼ -183.4% |
| 2010 | -30.54x | $-348.32K | $11.40K | ▼ -4175.9% |
| 2009 | -0.71x | $-10.22K | $14.31K | ▲ +29.5% |
| 2008 | -1.01x | $-23.03K | $22.74K | ▲ +51.3% |
| 2007 | -2.08x | $-3.12K | $1.50K | — |